Skip to main content
. Author manuscript; available in PMC: 2013 Jul 21.
Published in final edited form as: Anal Bioanal Chem. 2010 Dec 2;400(1):69–78. doi: 10.1007/s00216-010-4392-2

Table 4.

Extraction efficiency, process efficiency and matrix effect

Analyte Extraction efficiency (n=5)
Process efficiency (n=5)
Matrix effect (CV%) (n=10)
Low Medium High Low Medium High Low Medium High
EME 56.9 70.8 160.9 28.3 37.2 52.6 −53.3 (13.9) −63.3 (51.7) −63.3 (29.3)
BE 35.3 36.9 46.7 41.3 38.6 43.8 14.8 (2.7) 2.8 (3.0) −7.7 (2.3)
Cocaine 38.8 45.8 47.7 32.5 42.3 46.7 −14.1 (4.5) −9.3 (3.4) −3.7 (2.9)
Morphine 40.6 45.0 42.2 32.4 40.8 40.6 −19.2 (6.9) −11.9 (5.8) −6.0 (3.1)
Codeine 42.8 46.4 48.7 42.9 43.2 46.6 1.8 (3.3) −8.4 (3.7) −6.4 (3.4)
6AM 37.3 41.8 44.7 38.0 40.3 46.4 4.7 (4.7) −5.6 (7.4) 1.8 (3.5)
6AC 38.5 46.1 51.2 35.5 42.2 49.4 −8.2 (3.4) −9.7 (3.4) −5.5 (3.0)
Heroin 46.2 53.6 54.7 54.4 51.7 48.9 16.1 (5.6) −6.3 (9.3) −12.4 (3.7)
Cotinine 49.1 50.9 50.6 49.3 51.9 53.3 5.6 (8.1) −3.8 (7.6) 4.4 (3.2)
OH-Cotinine 39.2 45.6 45.7 37.4 45.4 44.7 −4.3 (3.0) 0.02 (2.6) −3.6 (2.7)
Methadone 54.5 54.1 58.4 46.2 56.3 62.3 −10.5 (9.8) −0.6 (7.6) 4.1 (6.6)
EDDP 63.5 51.3 52.2 25.5 25.7 49.5 −56.5 (21.2) −60.4 (36.0) −9.5 (7.6)
BUP 40.4 46.0 47.9 45.2 47.5 49.6 12.7 (2.4) 1.5 (2.9) 0.3 (4.5)
NBUP 65.4 54.4 52.8 91.7 55.7 50.5 42.6 (4.2) −2.1 (7.5) −7.0 (4.3)
HHS Vulnerability Disclosure